| 2025-08-20 | Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532,650.00 | -25.3% | → |
| 2025-06-05 | SANSONE GUY P | Director | Buy | 1,570 | $63.70 | $100,009.00 | +15.0% | → |
| 2025-05-06 | ROBBINS LARRY | - | Sell | 3,750,000 | $67.65 | $253,695,413.03 | -6.4% | → |
| 2025-03-05 | Clark James David | SVP, Cont & Chief Acct Officer | Sale+OE | 7,513 | $66.35 | $498,487.55 | -47.2% | → |
| 2025-02-18 | Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2,001,000.00 | +320.6% | → |
| 2024-10-23 | CAPOZZI HEIDI B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4,588.60 | +84.2% | → |
| 2024-05-02 | Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500,293.81 | +5,246% | → |
| 2024-05-02 | LUDWIG EDWARD J | Director | Buy | 1,000 | $53.88 | $53,879.00 | +4.8% | → |
| 2024-02-16 | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2,267,947.35 | -42.6% | → |
| 2023-11-03 | LUDWIG EDWARD J | Director | Buy | 2,000 | $70.47 | $140,930.00 | +10.7% | → |
| 2023-08-03 | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.92 | $1,930,003.88 | -44.2% | → |
| 2023-05-03 | Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976,567.20 | +3.4% | → |
| 2022-12-15 | Moriarty Thomas M | EVP & General Counsel | Sale+OE | 137,466 | $98.36 | $13,521,179.86 | -10.2% | → |
| 2022-08-04 | Lotvin Alan | EVP&President-PharmacyServices | Sale+OE | 143,440 | $98.94 | $14,192,366.00 | -30.5% | → |
| 2022-08-03 | Finke Daniel P | EVP/Pres, Health Care Benefits | Sale+OE | 9,546 | $100.00 | $954,600.00 | -22.9% | → |
| 2022-06-28 | Moriarty Thomas M | EVP & General Counsel | Sale+OE | 138,654 | $95.00 | $13,172,130.00 | -6.9% | → |
| 2022-04-08 | Shah Prem S | EVP and Co-President of Retail | Sale+OE | 16,954 | $105.00 | $1,780,170.00 | -6.9% | → |
| 2022-04-05 | Finke Daniel P | EVP/Pres, Health Care Benefits | Sale+OE | 61,300 | $100.12 | $6,137,196.67 | -26.4% | → |
| 2022-03-30 | Shah Prem S | EVP and Co-President of Retail | Sale+OE | 5,346 | $104.70 | $559,726.20 | -8.3% | → |
| 2022-03-17 | Shah Prem S | EVP and Co-President of Retail | Sale+OE | 4,624 | $106.65 | $493,149.60 | -3.8% | → |
| 2022-03-15 | Moriarty Thomas M | EVP & General Counsel | Sale+OE | 51,361 | $105.00 | $5,392,905.00 | -5.8% | → |
| 2022-02-10 | LUDWIG EDWARD J | Director | Buy | 1,000 | $105.90 | $105,904.40 | +5.8% | → |
| 2022-02-03 | Brennan Troyen A | EVP and Chief Medical Officer | Sale+OE | 47,937 | $110.00 | $5,273,070.00 | -25.7% | → |
| 2022-02-01 | Lotvin Alan | EVP&President-PharmacyServices | Sale+OE | 21,386 | $106.50 | $2,277,566.23 | -25.9% | → |
| 2022-01-28 | Clark James David | SVP, Cont & Chief Acct Officer | Sale+OE | 6,059 | $109.00 | $660,431.00 | -25.7% | → |
| 2022-01-27 | Roberts Jonathan C | EVP & Chief Operating Officer | Sale+OE | 68,482 | $107.50 | $7,361,815.00 | -39.0% | → |
| 2021-11-03 | Roberts Jonathan C | EVP & Chief Operating Officer | Sale+OE | 108,870 | $95.00 | $10,342,650.00 | -50.4% | → |
| 2021-11-01 | Brennan Troyen A | EVP and Chief Medical Officer | Sale+OE | 28,159 | $90.00 | $2,534,310.00 | -16.9% | → |
| 2021-10-26 | Brennan Troyen A | EVP and Chief Medical Officer | Sale+OE | 1,955 | $88.00 | $172,040.00 | -0.9% | → |